A Pilot Feasibility Study In The Detection And Monitoring Of Minimal Residual Disease In The Blood Of Patients Undergoing Treatment For High-Grade B
Posted Date: May 15, 2019
- Investigator: John Morris
- Type of Study: Observational/Survey
The purpose of this research study is to learn how tumor cells can be detected from blood as a marker of the activity of your disease.
Criteria:
To Be Eligible To Participate, Patients Must Have Been Diagnosed With Diffuse Large B Cell No-Hodgki
Keywords:
Lymphoma, Ucci-Hem-15-01, Hematologic Malignan, Phase I, Diffuse Large B Cell
For More Information:
Uc Cancer Center
513-584-7698
kastla@uc.edu